By: CNBC.com News
July 01, 2013 at 16:26 PM EDT
Let the Bids Begin! Pros See Higher Onyx Offers
Amgen's allegedly low-ball offer to buy Onyx Pharmaceuticals has set off a potential bidding war that could score much-bigger bucks for the cancer drugmaker while leaving biotech behemoth Amgen looking like a groom left behind at the altar, analysts said.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here